• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Viral hepatitis B during MIC

Viral hepatitis B during MIC

Paperback

Medical Reference

ISBN10: 6630136314
ISBN13: 9786630136319
Publisher: Our Knowledge Publishing
Published: Jun 15 2026
Pages: 60
Weight: 0.21
Height: 0.14 Width: 6.00 Depth: 9.00
Language: English
Immunosuppressants (IS) are a cornerstone of the management of inflammatory bowel disease (IBD), thereby increasing the risk of B-virus reactivation (rHVB). The prevalence of HBV infection among patients with IBD is higher than in the general population. Screening for HBV is mandatory in patients with IBD. In cases of IS treatment, HBV requires preemptive or, in some cases, prophylactic treatment depending on serostatus and the risk of reactivation. HBV vaccination is recommended for seronegative individuals.

Also from

Hassine, Hajer

Also in

Medical Reference